QS Investors’s NeoGenomics NEO Stock Holding History

QS Investors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,400	Closed	-$137K	–	1409
2020 Q2	$137K	Buy	+4,400	New	+$122K	﹤0.01%	1226
2019 Q1	–	Sell	-47	Closed	-$1K	–	1794
2018 Q4	$1K	Hold	47	–	–	﹤0.01%	1789
2018 Q3	$1K	Hold	47	–	–	﹤0.01%	1797
2018 Q2	$1K	Hold	47	–	–	﹤0.01%	1820
2018 Q1	$1K	Hold	47	–	–	﹤0.01%	1838
2017 Q4	$1K	Hold	47	–	–	﹤0.01%	1847
2017 Q3	$1K	Hold	47	–	–	﹤0.01%	1819
2017 Q2	$1K	Hold	47	–	–	﹤0.01%	1825
2017 Q1	$1K	Hold	47	–	–	﹤0.01%	1835
2016 Q4	$1K	Hold	47	–	–	﹤0.01%	1679
2016 Q3	$1K	Buy	47 +14	+42%	+$117	﹤0.01%	1668
2016 Q2	$1K	Buy	+33	New	+$265	﹤0.01%	1711

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

QS Investors's NEO Position: Q3 2020 in Review

QS Investors sold out of NeoGenomics (NEO) in Q3 2020, closing a stake of 4,400 shares — an estimated $137K sold.

QS Investors first reported a position in NEO in Q2 2016 and held it in 12 quarters. The position peaked at $137K in Q2 2020. 294 funds tracked by Wall St. Rank hold NEO as of Q3 2020.

QS Investors reported no remaining NeoGenomics position as of Q3 2020 after selling out during the quarter.
QS Investors sold 4,400 NeoGenomics shares in Q3 2020, an estimated $137K.
QS Investors first reported a position in NeoGenomics in Q2 2016 and held it in 12 quarters.
QS Investors's NeoGenomics position peaked at $137K in Q2 2020.
294 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.